Trial Profile
A Randomized, Double-blind, Placebo-controlled, Phase III Study in Patients With Metastatic Adenocarcinoma of the Colon or Rectum Who Are Receiving First-line Chemotherapy With Oxaliplatin/5-fluorouracil/Leucovorin With PTK787/ZK 222584 or Placebo.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Feb 2020
Price :
$35
*
At a glance
- Drugs Vatalanib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Adenocarcinoma; Colorectal cancer
- Focus Registrational; Therapeutic Use
- Acronyms CONFIRM-1
- Sponsors Novartis
- 04 Apr 2011 Results published in the Journal of Clinical Oncology.
- 04 Nov 2008 Updated from ClinicalTrials.gov record.
- 23 Sep 2007 Results were presented at ECCO 2007.